Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 1
2004 4
2005 5
2006 6
2007 4
2008 6
2009 5
2010 3
2011 3
2012 3
2013 3
2014 1
2015 2
2016 2
2017 1
2018 5
2019 5
2020 8
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Is Host Metabolism the Missing Link to Improving Cancer Outcomes?
Wright CM, Shastri AA, Bongiorno E, Palagani A, Rodeck U, Simone NL. Wright CM, et al. Among authors: rodeck u. Cancers (Basel). 2020 Aug 19;12(9):2338. doi: 10.3390/cancers12092338. Cancers (Basel). 2020. PMID: 32825010 Free PMC article. Review.
Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma.
Luginbuhl AJ, Johnson JM, Harshyne LA, Linnenbach AJ, Shukla SK, Alnemri A, Kumar G, Cognetti DM, Curry JM, Kotlov N, Antysheva Z, Degryse S, Mannion K, Gibson MK, Netterville J, Brown B, Axelrod R, Zinner R, Tuluc M, Gargano S, Leiby BE, Shimada A, Mahoney MG, Martinez-Outschoorn U, Rodeck U, Kim YJ, South AP, Argiris A. Luginbuhl AJ, et al. Among authors: rodeck u. Clin Cancer Res. 2022 Mar 1;28(5):915-927. doi: 10.1158/1078-0432.CCR-21-1816. Clin Cancer Res. 2022. PMID: 34911681 Free PMC article. Clinical Trial.
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer.
Jenkins KA, Park M, Pederzoli-Ribeil M, Eskiocak U, Johnson P, Guzman W, McLaughlin M, Moore-Lai D, O'Toole C, Liu Z, Nicholson B, Flesch V, Qiu H, Clackson T, O'Hagan RC, Rodeck U, Karow M, O'Neil J, Williams JC. Jenkins KA, et al. Among authors: rodeck u. J Immunother Cancer. 2023 Dec 12;11(12):e007785. doi: 10.1136/jitc-2023-007785. J Immunother Cancer. 2023. PMID: 38164757 Free PMC article.
Progress in epidermolysis bullosa research: toward treatment and cure.
Uitto J, McGrath JA, Rodeck U, Bruckner-Tuderman L, Robinson EC. Uitto J, et al. Among authors: rodeck u. J Invest Dermatol. 2010 Jul;130(7):1778-84. doi: 10.1038/jid.2010.90. Epub 2010 Apr 15. J Invest Dermatol. 2010. PMID: 20393479 Free article. Review.
74 results